These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
473 related items for PubMed ID: 22924987
1. Reduction of the risk of transfusion-transmitted viral infection by nucleic acid amplification testing in the Western Cape of South Africa: a 5-year review. Cable R, Lelie N, Bird A. Vox Sang; 2013 Feb; 104(2):93-9. PubMed ID: 22924987 [Abstract] [Full Text] [Related]
2. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, Le Roux M, Kuun E, Gulube S, Reddy R. Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474 [Abstract] [Full Text] [Related]
3. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value? Stramer SL, Zou S, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY. Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101 [Abstract] [Full Text] [Related]
4. Enhanced detection of hepatitis B virus in Hong Kong blood donors after introduction of a more sensitive transcription-mediated amplification assay. Tsoi WC, Lelie N, Lin CK. Transfusion; 2013 Oct; 53(10 Pt 2):2477-88. PubMed ID: 23521050 [Abstract] [Full Text] [Related]
7. Comparative analysis of triplex nucleic acid test assays in United States blood donors. Stramer SL, Krysztof DE, Brodsky JP, Fickett TA, Reynolds B, Dodd RY, Kleinman SH. Transfusion; 2013 Oct; 53(10 Pt 2):2525-37. PubMed ID: 23550838 [Abstract] [Full Text] [Related]
8. A mathematical approach to estimate the efficacy of individual-donation and minipool nucleic acid amplification test options in preventing transmission risk by window period and occult hepatitis B virus infections. Vermeulen M, van Drimmelen H, Coleman C, Mitchel J, Reddy R, Lelie N. Transfusion; 2014 Oct; 54(10):2496-504. PubMed ID: 24749834 [Abstract] [Full Text] [Related]
10. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009. Al Shaer L, AbdulRahman M, John TJ, AlHashimi A. Transfusion; 2012 Nov; 52(11):2300-9. PubMed ID: 22691239 [Abstract] [Full Text] [Related]
11. Hepatitis B virus transmission by blood transfusion during 4 years of individual-donation nucleic acid testing in South Africa: estimated and observed window period risk. Vermeulen M, Dickens C, Lelie N, Walker E, Coleman C, Keyter M, Reddy R, Crookes R, Kramvis A. Transfusion; 2012 Apr; 52(4):880-92. PubMed ID: 21981386 [Abstract] [Full Text] [Related]
12. Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety? Stramer SL, Notari EP, Krysztof DE, Dodd RY. Transfusion; 2013 Oct; 53(10 Pt 2):2449-58. PubMed ID: 23607261 [Abstract] [Full Text] [Related]
18. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load. Katsoulidou A, Moschidis Z, Sypsa V, Chini M, Papatheodoridis GV, Tassopoulos NC, Mimidis K, Karafoulidou A, Hatzakis A. Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585 [Abstract] [Full Text] [Related]
19. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection. Kiely P, Margaritis AR, Seed CR, Yang H, Australian Red Cross Blood Service NAT Study Group. Transfusion; 2014 Aug; 54(8):2084-91. PubMed ID: 24650170 [Abstract] [Full Text] [Related]